Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.7495
-0.0469 (-5.89%)
At close: Jun 3, 2025, 4:00 PM
0.7526
+0.0031 (0.41%)
After-hours: Jun 3, 2025, 7:17 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $139.48 million as of June 3, 2025. Its market cap has decreased by -56.59% in one year.
Market Cap
139.48M
Enterprise Value
105.49M
1-Year Change
-56.59%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $139.48M, a decrease of -70.86%. That is a compound annual growth rate of -4.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 29, 2025 | 137.50M | -19.83% |
Dec 31, 2024 | 171.50M | 59.09% |
Dec 29, 2023 | 107.80M | -74.62% |
Dec 30, 2022 | 424.80M | -82.96% |
Dec 31, 2021 | 2.49B | -18.24% |
Dec 31, 2020 | 3.05B | -19.69% |
Dec 31, 2019 | 3.80B | -33.26% |
Dec 31, 2018 | 5.69B | -39.50% |
Dec 29, 2017 | 9.40B | 401.47% |
Dec 30, 2016 | 1.88B | -16.61% |
Dec 31, 2015 | 2.25B | 12.95% |
Dec 31, 2014 | 1.99B | 51.06% |
Dec 31, 2013 | 1.32B | 54.43% |
Dec 31, 2012 | 853.40M | 33.30% |
Dec 30, 2011 | 640.20M | -47.19% |
Dec 31, 2010 | 1.21B | 39.56% |
Dec 31, 2009 | 868.60M | 68.99% |
Dec 31, 2008 | 514.00M | -16.91% |
Dec 31, 2007 | 618.60M | -54.96% |
Dec 29, 2006 | 1.37B | -4.78% |
Dec 30, 2005 | 1.44B | -15.13% |
Dec 31, 2004 | 1.70B | 122.51% |
Dec 31, 2003 | 763.80M | 70.57% |
Dec 31, 2002 | 447.80M | -56.04% |
Dec 31, 2001 | 1.02B | -55.42% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 662.23B |
Johnson & Johnson | 373.45B |
AbbVie | 328.75B |
Novo Nordisk | 305.07B |
UnitedHealth Group | 273.87B |
Abbott Laboratories | 232.41B |
AstraZeneca | 224.00B |
Novartis AG | 223.92B |